Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joan Chypyha Insider Profile
4 Followers
Joan Chypyha, Divisional President at Cipher Pharmaceuticals, holds 5.85K shares in Cipher Pharmaceuticals (Ticker: CPHRF), holds 300.00K shares in Ovation Science (Ticker: OVATF). Most recently, Joan Chypyha ― shares of Cipher Pharmaceuticals on ― for an estimated value of ―.
Joan Chypyha has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joan Chypyha holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Joan Chypyha
Joan Chypyha's Trading History
Cipher Pharmaceuticals
―
Divisional President
―
$38.90K
Ovation Science
―
Director
―
$12.30K
List of latest transactions for each holding click on a transaction to see Joan Chypyha's performance on stock
You May Also Like
Joan Chypyha insider profile FAQ
What is the percentage of profitable transactions made by Joan Chypyha?
The percentage of profitable transactions made by Joan Chypyha is ―.
What is the average return per transaction made by Joan Chypyha?
The average return per transaction made by Joan Chypyha is ―.
What stocks does Joan Chypyha hold?
Joan Chypyha holds: CPHRF, OVATF stocks.
What was Joan Chypyha’s latest transaction?
Joan Chypyha latest transaction was an Uninformative Buy of ―.
What was Joan Chypyha's most profitable transaction?
Joan Chypyha’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Joan Chypyha's role in Cipher Pharmaceuticals?
Joan Chypyha's role in Cipher Pharmaceuticals is Divisional President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.